Effect of Feedback and Practice on Probabilistic Decision Making in Attention Deficit and Hyperactivity Disorder

NCT ID: NCT01574976

Last Updated: 2015-11-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-05-31

Study Completion Date

2015-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine how feedback and practice affect decision making in adolescents with attention deficit and hyperactivity disorder.

Participants will have to choose between low and certain outcome and a higher but uncertain outcome, with or without serial feedback after each trial. Participants will perform the task twice to examine practice effects.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ADHD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control, no feeback

subjects without ADHD, probabilistic choices without feedback

Group Type ACTIVE_COMPARATOR

probabilistic choice

Intervention Type BEHAVIORAL

subjects should choose between low-certain outcome and high-uncertain outcome

control, feedback

subjects without ADHD, probabilistic choices with feedback

Group Type ACTIVE_COMPARATOR

probabilistic choice

Intervention Type BEHAVIORAL

subjects should choose between low-certain outcome and high-uncertain outcome

ADHD, no feedback

subjects with ADHD, probabilistic choices without feedback

Group Type EXPERIMENTAL

probabilistic choice

Intervention Type BEHAVIORAL

subjects should choose between low-certain outcome and high-uncertain outcome

adhd, feedback

subjects with ADHD, probabilistic choices with feedback

Group Type EXPERIMENTAL

probabilistic choice

Intervention Type BEHAVIORAL

subjects should choose between low-certain outcome and high-uncertain outcome

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

probabilistic choice

subjects should choose between low-certain outcome and high-uncertain outcome

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ADHD

Exclusion Criteria

* Current major depression,
* Psychosis,
* Autism,
* Tourette syndrome
Minimum Eligible Age

13 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shaare Zedek Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Yehuda Pollak

clinical neuropsychologist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yehuda Pollak, PhD

Role: PRINCIPAL_INVESTIGATOR

Shaare Zedek Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shaare Zedek Medical Center

Jerusalem, Israel, Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

37/12

Identifier Type: -

Identifier Source: org_study_id